HomeIMRX • NASDAQ
add
Immuneering Corp
Previous close
$2.09
Day range
$2.05 - $2.25
Year range
$1.00 - $8.89
Market cap
66.42M USD
Avg Volume
11.33M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 14.91M | 10.43% |
Net income | -14.08M | -15.52% |
Net profit margin | — | — |
Earnings per share | -0.47 | -9.30% |
EBITDA | -14.82M | -10.41% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 59.73M | -45.20% |
Total assets | 77.09M | -38.28% |
Total liabilities | 10.78M | 10.12% |
Total equity | 66.31M | — |
Shares outstanding | 29.65M | — |
Price to book | 0.93 | — |
Return on assets | -45.17% | — |
Return on capital | -48.51% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -14.08M | -15.52% |
Cash from operations | -11.53M | -7.23% |
Cash from investing | 4.97M | -45.79% |
Cash from financing | 0.00 | -100.00% |
Net change in cash | -6.56M | -124.67% |
Free cash flow | -6.79M | 1.37% |
About
Founded
2008
Website
Employees
66